Nobilis Health''s President Harry Fleming Interviewed by The Life Sciences Report
(firmenpresse) - SAN FRANCISCO, CA -- (Marketwired) -- 01/28/15 -- (TSX: NHC) has invented a genuine recipe for success: Provide outpatient surgical services with high profit margins and saturate a local consumer health market with advertising. The company is expected to close out 2014 with around $83 million ($83M) revenue while projecting 2015 revenue at $205M, a 147% increase. In this , Nobilis'' president Harry Fleming explains exactly how his booming firm''s business model works -- and why investors should take note of the new kid on the block.
Tell us a little bit about the financial history of Nobilis Health Corp.
The company was originally a rollup of ambulatory surgery centers -- outpatient centers. Back in 2007, when it was called Northstar Healthcare Inc., the company successfully launched a high-profile initial public offering (IPO) on the Toronto Stock Exchange for $150M. The IPO was very large for Canada. Dr. Donald Kramer, who is now our chairman, was CEO at the time. In 2010, he got crosswise with the Northstar board of directors and bought a controlling interest to fix some structural issues. The 2010 revenues were $12M. In 2013, revenue rose to $31M. We expect to hit $83M in 2014.
Ambulatory surgery is trending strongly in the U.S. We started out in Texas and Arizona. A recent acquisition has brought Nobilis Health ambulatory surgery centers to eight different states ranging from Minnesota to Florida. We are completing our U.S. registration statement for listing on the New York Stock Exchange...
Continue reading this interview with Harry Fleming:
Investors rely on to share investment ideas for the biotech, pharmaceutical, medical device, and diagnostics industries. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the causes of macro-economic shifts and the strategies that will help you capitalize on these developing trends.
Nobilis Health Inc. paid The Life Sciences Report to conduct, produce and distribute the interview. Harry Fleming had final approval of the content and is wholly responsible for the validity of the statements. Opinions expressed are the opinions of Harry Fleming and not of The Life Sciences Report or its officers.
The Life Sciences Report
Carrie Beal Amaro
Email:
Tel: 707-981-8999
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 28.01.2015 - 12:08 Uhr
Sprache: Deutsch
News-ID 1333285
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
SAN FRANCISCO, CA
Phone:
Kategorie:
Alternative
Anmerkungen:
Diese Pressemitteilung wurde bisher 212 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Nobilis Health''s President Harry Fleming Interviewed by The Life Sciences Report
"
steht unter der journalistisch-redaktionellen Verantwortung von
Streetwise Reports (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
